
Lilly Diabetes International
@LillyDiabetesIn
Followers
640
Following
0
Media
116
Statuses
122
Channel for the Professional Diabetes Community. Follow us for congress news, interviews & useful Diabetes info. X guidelines. https://t.co/uMMF5A4FXj
International
Joined April 2022
#DiabetesCare requires a multifactorial and holistic approach that goes beyond simply meeting HbA1c targets.¹,² Don’t miss out on more insights—follow us!
0
1
9
Globally, an estimated up to 45% of people with #Diabetes remain undiagnosed. At Lilly, we’re committed to raising awareness and supporting better access to care. Follow us for more insights!
0
2
12
Despite many advances in #T2D, we strive for new approaches to improve and transform care. Follow us for more insights!
3
0
12
How do you approach personalizing HbA1c targets for patients with #Type2Diabetes? The ADA/EASD consensus recommends personalizing glycemic targets based on each individual's preferences and characteristics. Follow for more!
0
2
14
Early detection of #Type2Diabetes and intensive glucose control from diagnosis can maximize reduction of the long-term risk of glycemic complications. But what factors influence the outcomes of early hyperglycemia? Follow us for more insights!
0
3
33
Could tighter HbA1c targets benefit some patients with #Type2Diabetes? Aiming for a lower HbA1c level than <7% may have value when it can be achieved without a large risk of hypoglycemia. Follow us for more!
1
1
26
What is therapeutic inertia in #Type2Diabetes? According to the ADA/EASD consensus, it occurs when goals or targets are not met, and diabetes management strategies are not adapted.¹ How to address and reduce the burden of therapeutic inertia in #Diabetes? Follow for more!
0
0
19
The UKPDS study found that early and tight glycemic control had a more significant impact on clinical outcomes than delayed glycemic control in patients with #Type2Diabetes. Follow our account for more insights!
1
6
51
Early and intensive glycemic control (HbA1c <7%/53 mmol/mol) can help prevent complications associated with type 2 diabetes (T2D). How do you discuss HbA1c goals with your patients with #T2D? Join the conversation and follow us for more!
0
3
36
#Type2diabetes is a very heterogeneous disease with variable age at onset, related degree of obesity, insulin resistance and tendency to develop complications. How can #DiabetesCare be tailored to respect and address these differences? Stay tuned and follow us for more!
0
8
25
Type 2 diabetes (T2D) is a complex disease characterized by its diversity and influenced by risk factors that can be either modifiable or inherent.¹,² How can we better address the challenges of managing T2D? Follow us for more insights on #DiabetesCare.
1
1
23
Is focusing on HbA1c targets enough in #Type2Diabetes (T2D) management? #T2D is a complex, chronic, heterogeneous disease that develops through diverse pathophysiological and molecular mechanisms.¹,² Follow us for more!
0
6
70
Proactive #DiabetesCare can help prevent complications and ensure better, healthier futures.¹⁻³ Stay tuned for more valuable insights!
0
0
5
Effective #DiabetesCare goes beyond one-size-fits-all solutions. A holistic, patient-centered approach to T2D involves regular assessments to adapt care and manage risk factors early.¹ Follow us for more insights.
0
1
8
The ADA/EASD consensus report 5S’s of daily physical activity can be key to effective #DiabetesCare.¹ A focus on exercise, activity, and reducing sedentary time is important for management of T2D.¹ Follow us for more insights!
1
3
18